Skip to main content
Clinical Trials/NCT04158167
NCT04158167
Completed
Not Applicable

Neurobiological Effects of Oxytocin on Metacognitive Deficits in Schizophrenia: A Pharmacological - Imaging Genetics Study

National Institute of Mental Health and Neuro Sciences, India1 site in 1 country90 target enrollmentSeptember 1, 2013
ConditionsSchizophrenia
Interventionsoxytocin

Overview

Phase
Not Applicable
Intervention
oxytocin
Conditions
Schizophrenia
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Enrollment
90
Locations
1
Primary Endpoint
fMRI changes with oxytocin
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

To investigate whether 24IU oxytocin can result in changes in functional brain connectivity in patients with schizophrenia and healthy individuals using functional magnetic resonance imaging (fMRI). The study will also examine the effect of oxytocin receptor gene polymorphism on the functional connectivity

Registry
clinicaltrials.gov
Start Date
September 1, 2013
End Date
December 30, 2018
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Sponsor
National Institute of Mental Health and Neuro Sciences, India
Responsible Party
Principal Investigator
Principal Investigator

Dr Naren P Rao

Additional Professor

National Institute of Mental Health and Neuro Sciences, India

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Schizophrenia subjects:
  • Inclusion criteria 1) Males between 18 and 50 years 2) Diagnosis of DSM-IV schizophrenia, schizoaffective or schizophreniform disorder 3) capacity to provide informed consent, as evaluated by the MacArthur Competence Assessment Tool for Clinical Research Exclusion criteria
  • General impairment in intellectual functioning
  • History of alcohol or substance dependence in the last 12 months (with the exception of nicotine)
  • Contraindication to oxytocin like hypersensitivity, vascular disease, chronic nephritis, epilepsy, asthma
  • Past history of head injury resulting in loss of consciousness or neurosurgery
  • Concomitant severe medical conditions
  • Metal implants or paramagnetic objects within the body or claustrophobia which may interfere with the MRI.
  • Healthy volunteers:
  • Inclusion criteria

Arms & Interventions

oxytocin

All subjects will receive both oxytocin and placebo in a counterbalanced design

Intervention: oxytocin

Outcomes

Primary Outcomes

fMRI changes with oxytocin

Time Frame: Upto 90 minutes after administration

changes in functional brain connectivity

Study Sites (1)

Loading locations...

Similar Trials